ArticleAnnals of surgical oncology2024

ASO Perspective Regarding Issues by the Phase II OPRA Trial and Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy.

Sergei Bedrikovetski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.